???UB recently received $4.9 million in funding for stem cell research from New York State as part of a $600 million research investment the state has set aside for the next 10 years.
???New York's leading stem cell research group, the New York State Stem Cell Science (NYSTEM), reviewed UB's research and recommended the university for the funding.
???"We have come a long way in stem cell research and transplantation," said Kenneth M. Tramposch, associate professor of pharmacology and toxicology. "This is because the time and money has been invested over the years. This is why it is so critical that NYSTEM and New York State really continue to federally fund this research."
???The university is studying stem cells that could potentially be used for neurodegenerative diseases like dementia and cardiac diseases. Research is focused on gaining a better understanding of basic biology of pluripotency, the concept that allows the stem cell to convert to any cells in the body, Tramposch said.
???Stem cell research may be able to generate brand new tissue in certain cases, and even cure diseases for which there are currently no adequate therapies. Diseases that could see revolutionary advances include Alzheimer's, Parkinson's, diabetes, spinal cord injury, heart disease, stroke, arthritis, cancer and burn injuries.
??The Department of Engineering is contributing to the research by working on methods to grow stem cells in large quantities.
???"It says a lot about UB and its level of research when we are recognized as a top of the line research university. When our own faculty wins so many awards on such a competitive topic says a lot. Being that we're able to contribute so much is very gratifying," Tramposch said. "I can't see any negatives that can result from this research. We just have to take the data as you get it, and decide what to do next."
???Other states, including California and Massachusetts, have also created long term funding plans for stem cell research.
Photo: Courtesy of Laron Fomby
